Price T Rowe Associates Inc. MD Invests $145,000 in Mineralys Therapeutics, Inc. (NASDAQ:MLYS)
Price T Rowe Associates Inc. MD bought a new position in Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 11,715 shares of the company’s stock, valued at approximately $145,000. Other hedge funds have also […]
Price T Rowe Associates Inc. MD bought a new position in Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 11,715 shares of the company’s stock, valued at approximately $145,000. Other hedge funds have also […]
